The delivery of interfering RNAs to lung tissue provides an opportunity to develop novel anti-viral and anti-inflammatory therapies for a variety of lung disorders. Intratracheal delivery of constructs for RNA interference (RNAi), as has been used to block influenza and parainfluenza lung infections, is a particularly exciting approach to treating lung disease because it offers potentially tissue-specific delivery of these molecules to a target organ. However, the cell types transduced with these methods are not yet known, and some investigators have found concerning non-specific effects in non-pulmonary tissues of mice exposed to this route of delivery. In addition, the potential for adverse effects in the lung, such as activation of inflammation are concerns that limit application of RNAi technology. Cell-specific, tissue-specific delivery of RNAi to immune cells within the lung would be a significant advance enabling potential treatment of many diseases characterized by inflammation, including asthma and emphysema. This grant application presents preliminary data demonstrating a novel lentiviral-based system that allows the cell-specific, tissue-specific in vivo delivery of RNAi to resident alveolar macrophages.
The specific aims of this proposal are designed to test the efficacy of this targeted in vivo delivery method and to understand the biology of this system, including screening for specificity and potential off-target effects. Finally, the system is applied for in vivo knockdown of NF-kB signaling in mouse alveolar macrophages and the treatment of tobacco smoke- induced lung inflammation. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21HL086414-02
Application #
7295731
Study Section
Special Emphasis Panel (ZRG1-BST-Z (52))
Program Officer
Punturieri, Antonello
Project Start
2006-09-30
Project End
2008-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
2
Fiscal Year
2007
Total Cost
$197,234
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Wilson, Andrew A; Kwok, Letty W; Porter, Emily L et al. (2013) Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol Ther 21:825-33
Wilson, Andrew A; Murphy, George J; Hamakawa, Hiroshi et al. (2010) Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. J Clin Invest 120:379-89
Murphy, Jaime; Summer, Ross; Wilson, Andrew A et al. (2008) The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 38:380-5
Wilson, Andrew A; Kwok, Letty W; Hovav, Avi-Hai et al. (2008) Sustained expression of alpha1-antitrypsin after transplantation of manipulated hematopoietic stem cells. Am J Respir Cell Mol Biol 39:133-41